Corbevex expected to get WHO prequalification, says Mahima Datla – ET HealthWorld
Hyderabad: Biological E’s COVID-19 vaccine candidate, Corbevex, is expected to get the World Health Organisation‘s (WHO) prequalification over the next…
Biological E
Continue reading
Corbevex expected to get WHO prequalification, says Mahima Datla – ET HealthWorld
Hyderabad: Biological E’s COVID-19 vaccine candidate, Corbevex, is expected to get the World Health Organisation‘s (WHO) prequalification over the next…
Covid-19 story not yet done: Mahima Datla – ET HealthWorld
Hyderabad: Vaccine maker Biological E‘s expects to get World Health Organisation (WHO) prequalification for its protein subunit Covid-19 vaccine Corbevax…
Genome Valley-like health city in Gr Noida – ET HealthWorld
Lucknow: Among several investors, Jeevropana Life Sciences has come with a plan to set up a healthcare city with an…
Biological E seeks nod for bivalent vax trials, Health News, ET HealthWorld
Hyderabad-based vaccine maker Biological E has sought the drug regulator’s permission to initiate clinical trials for its bivalent Covid-19 vaccine…
Biological E, Bharat Biotech Have 250 Million Covid Vaccine Stockpile: Report
Biological E Ltd and Bharat Biotech have a stock of 250 million doses of COVID-19 vaccines Hyderabad: Two major vaccine…
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses, Health News, ET HealthWorld
Hyderbad: Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses…
Hyderabad-Based Biological E Gets Approval For Pneumococcal Conjugate Vaccine
Hyderabad: Hyderabad-based pharmaceutical and vaccine manufacturer Biological E Limited (BE), on Friday announced that its 14-valent paediatric Pneumococcal Conjugate Vaccine…
Biological E plans to hive off non-vaccine business and sell stake – ET HealthWorld
Biological E (BE) said it is actively exploring the option of hiving off its non-vaccine business into a separate entity…
Bengaluru-based Eyestem raises $6.4 million in Series A round led by three pharma companies – ET HealthWorld
Bengaluru: Eyestem, a Bengaluru-based cell therapy company, has raised $6.4 million (Rs 51 crore) in a Series A round led…